20MP.F MOUNTAIN VALLEY MD HLDGS
- Market cap
- EUR 13.4M
- P/E
- -
- P/B
- 12.45x
- ROE
- -358.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 20MP.F undervalued?
Graham numberThe Graham number of MOUNTAIN VALLEY MD HLDGS cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MOUNTAIN VALLEY MD HLDGS fundamental analysis
No fundamental analysis for MOUNTAIN VALLEY MD HLDGS yet.
MOUNTAIN VALLEY MD HLDGS stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MOUNTAIN VALLEY MD HLDGS
The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant s…
Full company profileMOUNTAIN VALLEY MD HLDGS financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MOUNTAIN VALLEY MD HLDGS annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 110K | 0.00 | 60.0K | 49.0K | 65.0K | 124K |
| Gross Profit | 70.0K | 0.00 | - | - | - | - |
| Operating Income | -9.74M | -5.55M | -3.20M | -3.68M | -2.33M | -3.25M |
| EBITDA | - | -5.11M | -2.78M | -3.45M | -2.27M | -3.23M |
| Net Income | -9.71M | -7.44M | -7.67M | -7.47M | -2.80M | -6.21M |
| EPS | -0.03 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| Balance Sheet | ||||||
| Total Assets | 25.3M | 16.8M | 8.97M | 2.74M | 524K | 1.84M |
| Total Liabilities | 422K | 591K | 258K | 209K | 664K | 109K |
| Shareholders' Equity | 24.8M | 16.2M | 8.71M | 2.53M | -140K | 1.73M |
| Cash & Short-term Investments | 14.2M | 9.71M | 5.92M | 1.72M | 334K | 1.42M |
| Cash Flow | ||||||
| Operating Cash Flow | -5.59M | -4.79M | -3.30M | -3.90M | -2.11M | -3.38M |
| Capital Expenditure | 98.0K | 64.0K | 503K | 4.00K | 8.00K | 88.0K |
| Free Cash Flow | -5.68M | -4.85M | -3.80M | -3.91M | -2.12M | -3.47M |
| Ratios | ||||||
| ROE | -39.1% | -46.0% | -88.1% | -294.9% | - | -358.4% |
| ROA | -38.4% | -44.4% | -85.5% | -272.4% | -533.6% | -337.2% |
| Net Profit Margin | -8,826.4% | - | -12,783.3% | -15,249.0% | -4,301.5% | -5,006.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MOUNTAIN VALLEY MD HLDGS dividends
MOUNTAIN VALLEY MD HLDGS has not paid dividends in the last 5 fiscal years.
Who owns MOUNTAIN VALLEY MD HLDGS
- Insiders 0.90%
- Institutions 0.00%
- Public & others 99.10%
- Shares outstanding 352M
- Free float 445M
MOUNTAIN VALLEY MD HLDGS company profile
- Company name
- MOUNTAIN VALLEY MD HLDGS
- Ticker
- 20MP.F
- ISIN
- CA62430M1014
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- March
- Address
- 260 Edgeley Boulevard, Concord, ON, Canada, L4K 3Y4
- Phone
- 647-725-9755
- Website
- themorelife.company
About MOUNTAIN VALLEY MD HLDGS
The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant signalling technology. The company was formerly known as Mountain Valley MD Holdings Inc. and changed its name to The More Life Company Corp. in August 2026. The company is headquartered in Concord, Canada.
MOUNTAIN VALLEY MD HLDGS management
1- Mr. Dennis HancockCEO, President & Director